Notably, our findings demonstrated that the immune enhancement elicited by MWA in conjunction with Flt3L treatment significantly suppressed the growth of rechallenged tumors, indicating the potential to mitigate local recurrence and distant metastasis, which could offer substantial benefits for lung cancer patients. Here, FLT3LG is linked to lung cancer.